Parkinson’s disease affects more than 10 million people worldwide. Discover its causes, symptoms, and the latest innovations ...

Abstract and Introduction Impact of PD on HRQL Potential Impact of New Antiparkinsonian Agents on Hrql and Economic Outcomes Conclusion References Drugs that regulate the delivery of levodopa to ...

The total impact of PD and its treatment can be fully appreciated only when HRQL and economic outcomes, in addition to clinical outcomes, are examined. PD is associated with a marked deterioration ...

Dopamine, or a lack thereof, also plays a critical role in the onset of Parkinson's, a disease that afflicts an estimated 90,000 Americans every year. Treatment for Parkinson's focuses on managing ...

REM Sleep Behavior Disorder causes more than dream enactment—it’s a powerful clue to neurodegenerative disease risk.

Your T cells work hard to fight disease. Unfortunately, "friendly fire" from T cells can sometimes harm the body's healthy ...

Since Parkinson’s disease symptoms vary from person to person and there is no cure, treatment options vary as well. Levodopa is the most commonly used medication in Parkinson’s patients ...

(GERD) is a prevalent gastrointestinal disorder, with up to 20% of patients developing complications like Erosive ...

Roche RHHBY announced that it will advance pipeline candidate prasinezumab into phase III development for early-stage ...

Scientists are to examine whether drugs that are already in use could be repurposed to treat the symptoms of both Alzheimer’s disease and Parkinson’s in a new collaboration which aims to discover ...

The project is being funded under a $25 million research grant awarded on May 28 to the institute by the National Medical Research Council for five years to study Parkinson’s disease.